Clinical Value of Metagenomic Sequencing in Neonatal Sepsis

NCT05416918 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2023-12-28

No results posted yet for this study

Summary

This study aimed to enroll 2000 neonatal patients with suspected sepsis or clinical diagnosed sepsis. These patients will undergo both conventional methods and metagenomics sequencing to detect the pathogenic microorganisms of sepsis. The purpose of this study was to assess the clinical value of metagenomics sequencing for the diagnosis and treatment of neonatal sepsis.

Conditions

  • Neonatal Sepsis

Sponsors & Collaborators

  • Quanzhou Women's and Children's Hospital

    collaborator UNKNOWN
  • Shengjing Hospital

    collaborator OTHER
  • Jiangxi Maternal and Child Health Hospital

    collaborator OTHER
  • Northwest Women's and Children's Hospital, Xi'an, Shaanxi

    collaborator OTHER
  • Nanjing Maternity and Child Health Care Hospital

    collaborator OTHER
  • The First Hospital of Jilin University

    collaborator OTHER
  • Hunan Children's Hospital

    collaborator OTHER_GOV
  • Henan Provincial People's Hospital

    collaborator OTHER
  • Tianjin Central Hospital of Gynecology Obstetrics

    collaborator OTHER
  • Jiangxi Children's Hospital

    collaborator UNKNOWN
  • Maternal and Child Health Hospital of Guangxi Zhuang Autonomous Region

    collaborator OTHER
  • Xinjiang Children's Hospital

    collaborator UNKNOWN
  • Shenzhen Maternity and Child Healthcare Hospital

    collaborator UNKNOWN
  • Children's Hospital of Nanjing Medical University

    collaborator OTHER
  • Gansu Provincial Maternal and Child Health Care Hospital

    collaborator OTHER
  • Kunming Children's Hospital

    collaborator OTHER
  • Fujian Provincial Maternity and Children

    collaborator UNKNOWN
  • Zhuhai Women and Children's Hospital

    collaborator UNKNOWN
  • Xiamen Children's Hospital

    collaborator OTHER
  • Children's Hospital Affiliated to Shandong University

    collaborator UNKNOWN
  • Henan Maternal and Child Health Care Hospital

    collaborator UNKNOWN
  • Wuhan Children's Hospital

    collaborator OTHER
  • Children's Hospital of Fudan University

    lead OTHER

Principal Investigators

  • Wenhao Zhou, Doctor · Children's Hospital of Fudan University

Eligibility

Min Age
0 Days
Max Age
28 Days
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-04-01
Primary Completion
2022-12-01
Completion
2022-12-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05416918 on ClinicalTrials.gov